A rare cause of hemoptysis

Respiratory Medicine Case Reports

Volumn 13, Issue , 2014, Pages 48-50

  Aversa, Meghan ^a   Bhinder, Sacha ^a   Tanguay, Jeffrey ^a   Thenganatt, John ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Diffuse pulmonary hemorrhage; Metastatic angiosarcoma

Indexed keywords

ADULT; ANGIOSARCOMA; ARTICLE; CASE REPORT; CHINESE; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; HEMOPTYSIS; HUMAN; LUNG HEMORRHAGE; MALE; OPEN LUNG BIOPSY; PNEUMOTHORAX; PRIMARY TUMOR; THORAX PAIN;

EID: 84910083783     PISSN: None     EISSN: 22130071     Source Type: Journal    
DOI: 10.1016/j.rmcr.2014.08.001     Document Type: Article

References (23)

1. Patel A.M., Ryu J.H. Angiosarcoma in the lung. Chest 1993, 103:1531-1535.
2. Ravi V., Patel S. Vascular sarcomas. Curr Oncol Rep 2013, 15:347-355.
3. Adem C., Aubry M.C., Tazelaar H.D., Myers J.L. Metastatic angiosarcoma masquerading as diffuse pulmonary hemorrhage: clinicopathologic analysis of 7 new patients. Arch Pathol Lab Med 2001, 125:1562-1565.
4. Zwaveling J.H., van Berkhout F.T., Haneveld G.T. Angiosarcoma of the heart presenting as pulmonary disease. Chest 1988, 94:216-218.
5. Edwards R.L., Chalk S.M., McEvoy J.D.S., Donald K.J. Pulmonary haemorrhage in disseminated cardiac haemangiosarcoma. Br J Dis Chest 1977, 71:127-131.
6. Ebi N., Yamamoto H., Sakai J., Sugahara K., Arimura H., Nakanishi K. Angiosarcoma of the heart presenting as fatal pulmonary hemorrhage. Intern Med 1997, 36:191-193.
7. Bic J.F., Fade-Schneller O., Marie B., Neimann J.L., Anthoine D., Martinet Y. Cardiac angiosarcoma revealed by lung metastases. Eur Respir J 1994, 7:1194-1196.
8. Romero-Menor C., Vadillo M., Martin F., Romagosa V., Corbella X. Cardiac angiosarcoma presenting as diffuse pulmonary disease. Eur Heart J 1995, 16:2005-2006.
9. Nara M., Sasaki T., Shimura S., Yamamoto M., Oshiro T., Kaiwa Y., et al. Diffuse alveolar hemorrhage caused by lung metastasis of ovarian angiosarcoma. Intern Med 1996, 35:653-656.
10. Rai S., Barthwal M., Bhattacharya P., Bhargava S., Pethe M. Metastatic angiosarcoma presenting as diffuse alveolar hemorrhage. Lung India 2008, 25:14-16.
11. Bocklage T., Leslie K., Yousem S., Colby T. Extracutaneous angiosarcomas metastatic to the lungs: clinical and pathologic features of twenty-one cases. Mod Pathol 2001, 14:1216-1225.
12. Tateishi U., Hasegawa T., Kusumoto M., Yamazaki N., Iinuma G., Muramatsu Y., et al. Metastatic angiosarcoma of the lung: spectrum of CT findings. AJR Am J Roentgenol 2003, 180:1671-1674.
13. Krenke R., Klimiuk J., Korczynski P., Kupis W., Szolkowska M., Chazan R. Hemoptysis and spontaneous hemothorax in a patient with multifocal nodular lung lesions. Chest 2011, 140:245-251.
14. Chen Y., Guo L., Yang L., Feng W., Zhang X.Q., Ling C.H., et al. Angiosarcoma of the lung: 2 case reports and literature reviewed. Lung Cancer 2010, 70:352-356.
15. Penel N., Marreaud S., Robin Y.M., Hohenberger R. Angiosarcoma: state of the art and perspectives. Crit Rev Oncol Hematol 2011, 80:257-263.
16. Fury M.G., Antonescu C.R., Van Zee K.J., Brennan M.F., Maki R.G. A14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J 2005, 11:241-247.
17. Penel N., Bui B.N., Bay J.O., Cupissol D., Ray-Coquard I., Piperno-Neumann S., et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the AngioTax study. JClin Oncol 2008, 26:5269-5274.
18. Stacchiotti S., Palassini E., Sanfilippo R., Vincenzi B., Arena M.G., Bochicchio A.M., et al. Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network. Ann Oncol 2012, 23:501-508.
19. Leu K.M., Ostruszka L.J., Shewach D., Zalupski M., Sondak V., Biermann J.S., et al. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma. JClin Oncol 2004, 22:1706-1712.
20. European Sarcoma Network Working Group Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012, 23(Suppl.7):vii92-vii99.
21. Maki R.G., D'Adamo D.R., Keohan M.L., Saulle M., Schuetze S.M., Undevia S.D., et al. Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. JClin Oncol 2009, 27:3133-3140.
22. Chugh R., Wathen J.K., Maki R.G., Benjamin R.S., Patel S.R., Meyers P.A., et al. Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a Bayesian hierarchial statistical model. JClin Oncol 2009, 27:3148-3153.
23. Agulnik M., Yarber J.L., Okuno S.H., von Mehren M., Jovanovic B.D., Brockstein B.E., et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 2013, 24:257-263.